Investigators analyzed economic evaluations of adjuvant immunotherapy to assess cost-effectiveness outcomes, quality-adjusted life-year (QALY)/life-year (LY) gains, and methodologic approaches.

What Is Adjuvant Chemotherapy (Preventive Chemotherapy)? Adjuvant chemotherapy – also called preventive chemotherapy – is a cancer treatment you get after surgery, radiation, or other main treatments ...

SAN FRANCISCO -- The use of adjuvant pembrolizumab (Keytruda) boosted overall survival (OS) in post-surgical patients with clear cell renal cell carcinoma (RCC) at risk for recurrence, according to ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

Adjuvant systemic therapy was associated with improved rates of overall survival among patients who underwent surgical resection for MM.

Among premenopausal women with hormone receptor–positive breast cancer, risk stratification strategies can help determine prognosis and tailor optimal chemotherapy and endocrine therapy decisions.

Cancer has evolved to protect itself from our inherent immune responses, and some types of cancer cells have developed their own strategies to evade or withstand treatment. These pro-cancer shields ...

Women with primary invasive breast cancer receive both local and systemic treatment. Surgery and radiation therapy are local treatments given to reduce the risk of recurrent cancer in the breast, ...

For the last 20 years, the standard-of-care adjuvant treatment for resected pathologically defined high-risk resected locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) has been ...